| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 66.66 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 66.66. The average price that CVS shares were previous bought at was USD 63.5284. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 165,130 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -23 @ USD 141.84 | USD -3,262 | The ETF sold 23 shares of DVA on 2025-07-09. The shares were previously bought for an average price of USD 152.044. The DaVita HealthCare Partners Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 235 The average price that the ETF previously sold DVA share for is USD 147.925 which is higher than the selling price of USD 141.84 on 2025-07-09. |
| CRL - Creightons Plc | SELL | -27 @ USD 158.97 | USD -4,292 | The ETF sold 27 shares of CRL on 2025-07-09. The shares were previously bought for an average price of USD 166.023. The Creightons Plc shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 190 The average price that the ETF previously sold CRL share for is USD 175.464 which is higher than the selling price of USD 158.97 on 2025-07-09. |
| TECH - Bio-Techne Corp | SELL | -86 @ USD 52.59 | USD -4,523 | The ETF sold 86 shares of TECH on 2025-07-09. The shares were previously bought for an average price of USD 62.9582. The Bio-Techne Corp shares were sold for -16.5% lower than average price of previous purchases. This resulted in an overall loss of USD 892 The average price that the ETF previously sold TECH share for is USD 67.3453 which is higher than the selling price of USD 52.59 on 2025-07-09. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 74.16 | USD -5,117 | The ETF sold 69 shares of HSIC on 2025-07-09. The shares were previously bought for an average price of USD 72.5313. The Henry Schein Inc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 112 The average price that the ETF previously sold HSIC share for is USD 71.2688 so the ETF has sold 69 shares on 2025-07-09 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 182.56 | USD -5,659 | The ETF sold 31 shares of UHS on 2025-07-09. The shares were previously bought for an average price of USD 186.901. The Universal Health Services Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 135 The average price that the ETF previously sold UHS share for is USD 190.228 which is higher than the selling price of USD 182.56 on 2025-07-09. |
| SOLV - Solventum Corp. | SELL | -77 @ USD 74.19 | USD -5,713 | The ETF sold 77 shares of SOLV on 2025-07-09. The shares were previously bought for an average price of USD 73.9165. The Solventum Corp. shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 21 The average price that the ETF previously sold SOLV share for is USD 70.9369 so the ETF has sold 77 shares on 2025-07-09 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -184 @ USD 32.79 | USD -6,033 | The ETF sold 184 shares of MRNA on 2025-07-09. The shares were previously bought for an average price of USD 34.1169. The Moderna Inc shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 244 The average price that the ETF previously sold MRNA share for is USD 39.2889 which is higher than the selling price of USD 32.79 on 2025-07-09. |
| INCY - Incyte Corporation | SELL | -89 @ USD 68.72 | USD -6,116 | The ETF sold 89 shares of INCY on 2025-07-09. The shares were previously bought for an average price of USD 68.9686. The Incyte Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 22 The average price that the ETF previously sold INCY share for is USD 71.8196 which is higher than the selling price of USD 68.72 on 2025-07-09. |
| VTRS - Viatris Inc | SELL | -667 @ USD 9.23 | USD -6,156 | The ETF sold 667 shares of VTRS on 2025-07-09. The shares were previously bought for an average price of USD 10.2249. The Viatris Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 664 The average price that the ETF previously sold VTRS share for is USD 11.6003 which is higher than the selling price of USD 9.23 on 2025-07-09. |
| RVTY - Revvity Inc. | SELL | -65 @ USD 100.13 | USD -6,508 | The ETF sold 65 shares of RVTY on 2025-07-09. The shares were previously bought for an average price of USD 110.032. The Revvity Inc. shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 644 The average price that the ETF previously sold RVTY share for is USD 109.381 which is higher than the selling price of USD 100.13 on 2025-07-09. |
| MOH - MOH | SELL | -30 @ USD 237.22 | USD -7,117 | The ETF sold 30 shares of MOH on 2025-07-09. The shares were previously bought for an average price of USD 306.545. The MOH shares were sold for -22.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,080 The average price that the ETF previously sold MOH share for is USD 304.926 which is higher than the selling price of USD 237.22 on 2025-07-09. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 237.22 | USD -7,117 | The ETF sold 30 shares of MOH on 2025-07-09. The shares were previously bought for an average price of USD 306.545. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -22.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,080 The average price that the ETF previously sold MOH share for is USD 304.926 which is higher than the selling price of USD 237.22 on 2025-07-09. |
| ALGN - Align Technology Inc | SELL | -37 @ USD 200.48 | USD -7,418 | The ETF sold 37 shares of ALGN on 2025-07-09. The shares were previously bought for an average price of USD 187.06. The Align Technology Inc shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 497 The average price that the ETF previously sold ALGN share for is USD 206.512 which is higher than the selling price of USD 200.48 on 2025-07-09. |
| HOLX - Hologic Inc | SELL | -124 @ USD 65.85 | USD -8,165 | The ETF sold 124 shares of HOLX on 2025-07-09. The shares were previously bought for an average price of USD 66.5861. The Hologic Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 91 The average price that the ETF previously sold HOLX share for is USD 71.002 which is higher than the selling price of USD 65.85 on 2025-07-09. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -111 @ USD 74.95 | USD -8,319 | The ETF sold 111 shares of COO on 2025-07-09. The shares were previously bought for an average price of USD 86.8441. The The Cooper Companies, Inc. Common Stock shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,320 The average price that the ETF previously sold COO share for is USD 92.1571 which is higher than the selling price of USD 74.95 on 2025-07-09. |
| BAX - Baxter International Inc | SELL | -287 @ USD 29.81 | USD -8,555 | The ETF sold 287 shares of BAX on 2025-07-09. The shares were previously bought for an average price of USD 32.4244. The Baxter International Inc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 750 The average price that the ETF previously sold BAX share for is USD 32.1594 which is higher than the selling price of USD 29.81 on 2025-07-09. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 226.18 | USD -8,821 | The ETF sold 39 shares of WST on 2025-07-09. The shares were previously bought for an average price of USD 251.218. The West Pharmaceutical Services Inc shares were sold for -10.0% lower than average price of previous purchases. This resulted in an overall loss of USD 976 The average price that the ETF previously sold WST share for is USD 291.108 which is higher than the selling price of USD 226.18 on 2025-07-09. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 33.09 | USD -9,133 | The ETF sold 276 shares of CNC on 2025-07-09. The shares were previously bought for an average price of USD 59.2099. The Concurrent Technologies Plc shares were sold for -44.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,209 The average price that the ETF previously sold CNC share for is USD 59.2432 which is higher than the selling price of USD 33.09 on 2025-07-09. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 95.2 | USD -10,377 | The ETF sold 109 shares of ZBH on 2025-07-09. The shares were previously bought for an average price of USD 104.881. The Zimmer Biomet Holdings Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,055 The average price that the ETF previously sold ZBH share for is USD 105.177 which is higher than the selling price of USD 95.2 on 2025-07-09. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 173.62 | USD -10,764 | The ETF sold 62 shares of DGX on 2025-07-09. The shares were previously bought for an average price of USD 168.441. The Quest Diagnostics Incorporated shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 321 The average price that the ETF previously sold DGX share for is USD 162.713 so the ETF has sold 62 shares on 2025-07-09 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -81 @ USD 133.02 | USD -10,775 | The ETF sold 81 shares of BIIB on 2025-07-09. The shares were previously bought for an average price of USD 141.02. The Biogen Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 648 The average price that the ETF previously sold BIIB share for is USD 153.143 which is higher than the selling price of USD 133.02 on 2025-07-09. |
| WAT - Waters Corporation | SELL | -32 @ USD 349.21 | USD -11,175 | The ETF sold 32 shares of WAT on 2025-07-09. The shares were previously bought for an average price of USD 362.82. The Waters Corporation shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 436 The average price that the ETF previously sold WAT share for is USD 368.554 which is higher than the selling price of USD 349.21 on 2025-07-09. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 349.21 | USD -11,175 | The ETF sold 32 shares of WAT on 2025-07-09. The shares were previously bought for an average price of USD 362.82. The MULETFWATIMETFP shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 436 The average price that the ETF previously sold WAT share for is USD 368.554 which is higher than the selling price of USD 349.21 on 2025-07-09. |
| PODD - Insulet Corporation | SELL | -38 @ USD 297.46 | USD -11,303 | The ETF sold 38 shares of PODD on 2025-07-09. The shares were previously bought for an average price of USD 277.376. The Insulet Corporation shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 763 The average price that the ETF previously sold PODD share for is USD 269.863 so the ETF has sold 38 shares on 2025-07-09 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -46 @ USD 259.07 | USD -11,917 | The ETF sold 46 shares of LH on 2025-07-09. The shares were previously bought for an average price of USD 246.13. The Laboratory Corporation of America Holdings shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 595 The average price that the ETF previously sold LH share for is USD 239.554 so the ETF has sold 46 shares on 2025-07-09 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -55 @ USD 231.28 | USD -12,720 | The ETF sold 55 shares of STE on 2025-07-09. The shares were previously bought for an average price of USD 223.954. The STERIS plc shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 403 The average price that the ETF previously sold STE share for is USD 219.522 so the ETF has sold 55 shares on 2025-07-09 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1218.65 | USD -13,405 | The ETF sold 11 shares of MTD on 2025-07-09. The shares were previously bought for an average price of USD 1228.19. The Mettler-Toledo International Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 105 The average price that the ETF previously sold MTD share for is USD 1229.59 which is higher than the selling price of USD 1218.65 on 2025-07-09. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1218.65 | USD -13,405 | The ETF sold 11 shares of MTD on 2025-07-09. The shares were previously bought for an average price of USD 1228.19. The AMUNDI EUR GOV 710 shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 105 The average price that the ETF previously sold MTD share for is USD 1229.59 which is higher than the selling price of USD 1218.65 on 2025-07-09. |
| IQV - IQVIA Holdings Inc | SELL | -90 @ USD 162.02 | USD -14,582 | The ETF sold 90 shares of IQV on 2025-07-09. The shares were previously bought for an average price of USD 186.439. The IQVIA Holdings Inc shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,198 The average price that the ETF previously sold IQV share for is USD 189.274 which is higher than the selling price of USD 162.02 on 2025-07-09. |
| HUM - Hummingbird Resources PLC | SELL | -67 @ USD 236.7 | USD -15,859 | The ETF sold 67 shares of HUM on 2025-07-09. The shares were previously bought for an average price of USD 263.605. The Hummingbird Resources PLC shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,803 The average price that the ETF previously sold HUM share for is USD 271.086 which is higher than the selling price of USD 236.7 on 2025-07-09. |
| HUM - Humana Inc | SELL | -67 @ USD 236.7 | USD -15,859 | The ETF sold 67 shares of HUM on 2025-07-09. The shares were previously bought for an average price of USD 263.605. The Humana Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,803 The average price that the ETF previously sold HUM share for is USD 271.086 which is higher than the selling price of USD 236.7 on 2025-07-09. |
| DXCM - DexCom Inc | SELL | -217 @ USD 84.87 | USD -18,417 | The ETF sold 217 shares of DXCM on 2025-07-09. The shares were previously bought for an average price of USD 78.3581. The DexCom Inc shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 1,413 The average price that the ETF previously sold DXCM share for is USD 77.0811 so the ETF has sold 217 shares on 2025-07-09 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -255 @ USD 75.51 | USD -19,255 | The ETF sold 255 shares of GEHC on 2025-07-09. The shares were previously bought for an average price of USD 82.0681. The GE HealthCare Technologies Inc. shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,672 The average price that the ETF previously sold GEHC share for is USD 79.7888 which is higher than the selling price of USD 75.51 on 2025-07-09. |
| A - Agilent Technologies Inc | SELL | -159 @ USD 121.3 | USD -19,287 | The ETF sold 159 shares of A on 2025-07-09. The shares were previously bought for an average price of USD 126.417. The Agilent Technologies Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 814 The average price that the ETF previously sold A share for is USD 130.254 which is higher than the selling price of USD 121.3 on 2025-07-09. |
| RMD - ResMed Inc | SELL | -81 @ USD 255.98 | USD -20,734 | The ETF sold 81 shares of RMD on 2025-07-09. The shares were previously bought for an average price of USD 237.406. The ResMed Inc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 1,504 The average price that the ETF previously sold RMD share for is USD 242.155 so the ETF has sold 81 shares on 2025-07-09 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -132 @ USD 164.26 | USD -21,682 | The ETF sold 132 shares of CAH on 2025-07-09. The shares were previously bought for an average price of USD 132.76. The Cardinal Health Inc shares were sold for 23.7% higher than average price of previous purchases. This sale made a profit of USD 4,158 The average price that the ETF previously sold CAH share for is USD 129.985 so the ETF has sold 132 shares on 2025-07-09 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 540.64 | USD -23,788 | The ETF sold 44 shares of IDXX on 2025-07-09. The shares were previously bought for an average price of USD 451.69. The IDEXX Laboratories Inc shares were sold for 19.7% higher than average price of previous purchases. This sale made a profit of USD 3,914 The average price that the ETF previously sold IDXX share for is USD 443.199 so the ETF has sold 44 shares on 2025-07-09 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -326 @ USD 77.19 | USD -25,164 | The ETF sold 326 shares of EW on 2025-07-09. The shares were previously bought for an average price of USD 71.5785. The Edwards Lifesciences Corp shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 1,829 The average price that the ETF previously sold EW share for is USD 71.1514 so the ETF has sold 326 shares on 2025-07-09 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -159 @ USD 175.5 | USD -27,905 | The ETF sold 159 shares of BDX on 2025-07-09. The shares were previously bought for an average price of USD 219.065. The Becton Dickinson and Company shares were sold for -19.9% lower than average price of previous purchases. This resulted in an overall loss of USD 6,927 The average price that the ETF previously sold BDX share for is USD 215.12 which is higher than the selling price of USD 175.5 on 2025-07-09. |
| COR - Cencora Inc. | SELL | -95 @ USD 300.16 | USD -28,515 | The ETF sold 95 shares of COR on 2025-07-09. The shares were previously bought for an average price of USD 261.802. The Cencora Inc. shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of USD 3,644 The average price that the ETF previously sold COR share for is USD 253.451 so the ETF has sold 95 shares on 2025-07-09 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -58 @ USD 552.58 | USD -32,050 | The ETF sold 58 shares of REGN on 2025-07-09. The shares were previously bought for an average price of USD 679.66. The Regeneron Pharmaceuticals Inc shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,371 The average price that the ETF previously sold REGN share for is USD 708.031 which is higher than the selling price of USD 552.58 on 2025-07-09. |
| HCA - HCA Holdings Inc | SELL | -96 @ USD 378.44 | USD -36,330 | The ETF sold 96 shares of HCA on 2025-07-09. The shares were previously bought for an average price of USD 342.952. The HCA Holdings Inc shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 3,407 The average price that the ETF previously sold HCA share for is USD 337.736 so the ETF has sold 96 shares on 2025-07-09 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -246 @ USD 158.27 | USD -38,934 | The ETF sold 246 shares of ZTS on 2025-07-09. The shares were previously bought for an average price of USD 166.363. The Zoetis Inc shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,991 The average price that the ETF previously sold ZTS share for is USD 169.674 which is higher than the selling price of USD 158.27 on 2025-07-09. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 346.36 | USD -43,295 | The ETF sold 125 shares of ELV on 2025-07-09. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,405 The average price that the ETF previously sold ELV share for is USD 396.876 which is higher than the selling price of USD 346.36 on 2025-07-09. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 346.36 | USD -43,295 | The ETF sold 125 shares of ELV on 2025-07-09. The shares were previously bought for an average price of USD 405.601. The Elevance Health Inc shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,405 The average price that the ETF previously sold ELV share for is USD 396.876 which is higher than the selling price of USD 346.36 on 2025-07-09. |
| CI - Cigna Corp | SELL | -148 @ USD 309.78 | USD -45,847 | The ETF sold 148 shares of CI on 2025-07-09. The shares were previously bought for an average price of USD 316.282. The Cigna Corp shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 962 The average price that the ETF previously sold CI share for is USD 313.302 which is higher than the selling price of USD 309.78 on 2025-07-09. |
| MCK - McKesson Corporation | SELL | -69 @ USD 727.23 | USD -50,179 | The ETF sold 69 shares of MCK on 2025-07-09. The shares were previously bought for an average price of USD 639.059. The McKesson Corporation shares were sold for 13.8% higher than average price of previous purchases. This sale made a profit of USD 6,084 The average price that the ETF previously sold MCK share for is USD 618.884 so the ETF has sold 69 shares on 2025-07-09 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,133 @ USD 47.66 | USD -53,999 | The ETF sold 1133 shares of BMY on 2025-07-09. The shares were previously bought for an average price of USD 55.4006. The Bloomsbury Publishing Plc shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,770 The average price that the ETF previously sold BMY share for is USD 55.0632 which is higher than the selling price of USD 47.66 on 2025-07-09. |
| MDT - Medtronic PLC | SELL | -714 @ USD 89 | USD -63,546 | The ETF sold 714 shares of MDT on 2025-07-09. The shares were previously bought for an average price of USD 88.3291. The Medtronic PLC shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 479 The average price that the ETF previously sold MDT share for is USD 85.5592 so the ETF has sold 714 shares on 2025-07-09 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -142 @ USD 478.965 | USD -68,013 | The ETF sold 142 shares of VRTX on 2025-07-09. The shares were previously bought for an average price of USD 472.108. The Vertex Pharmaceuticals Inc shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 974 The average price that the ETF previously sold VRTX share for is USD 461.505 so the ETF has sold 142 shares on 2025-07-09 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -354 @ USD 200.96 | USD -71,140 | The ETF sold 354 shares of DHR on 2025-07-09. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,552 The average price that the ETF previously sold DHR share for is USD 226.041 which is higher than the selling price of USD 200.96 on 2025-07-09. |
| DHR - Danaher Corporation | SELL | -354 @ USD 200.96 | USD -71,140 | The ETF sold 354 shares of DHR on 2025-07-09. The shares were previously bought for an average price of USD 213.818. The Danaher Corporation shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,552 The average price that the ETF previously sold DHR share for is USD 226.041 which is higher than the selling price of USD 200.96 on 2025-07-09. |
| SYK - Stryker Corporation | SELL | -191 @ USD 392.05 | USD -74,882 | The ETF sold 191 shares of SYK on 2025-07-09. The shares were previously bought for an average price of USD 378.931. The Stryker Corporation shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 2,506 The average price that the ETF previously sold SYK share for is USD 376.546 so the ETF has sold 191 shares on 2025-07-09 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -692 @ USD 113.24 | USD -78,362 | The ETF sold 692 shares of GILD on 2025-07-09. The shares were previously bought for an average price of USD 103.816. The Guild Esports Plc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 6,521 The average price that the ETF previously sold GILD share for is USD 96.6356 so the ETF has sold 692 shares on 2025-07-09 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,165 @ USD 25.56 | USD -80,897 | The ETF sold 3165 shares of PFE on 2025-07-09. The shares were previously bought for an average price of USD 25.4721. The Pfizer Inc shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of USD 278 The average price that the ETF previously sold PFE share for is USD 25.6528 which is higher than the selling price of USD 25.56 on 2025-07-09. |
| BSX - Boston Scientific Corporation | SELL | -824 @ USD 102.96 | USD -84,839 | The ETF sold 824 shares of BSX on 2025-07-09. The shares were previously bought for an average price of USD 99.2677. The Boston Scientific Corporation shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 3,042 The average price that the ETF previously sold BSX share for is USD 92.5199 so the ETF has sold 824 shares on 2025-07-09 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -824 @ USD 102.96 | USD -84,839 | The ETF sold 824 shares of BSX on 2025-07-09. The shares were previously bought for an average price of USD 99.2677. The MULSTRXSSXIMETFP shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 3,042 The average price that the ETF previously sold BSX share for is USD 92.5199 so the ETF has sold 824 shares on 2025-07-09 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -210 @ USD 419.88 | USD -88,175 | The ETF sold 210 shares of TMO on 2025-07-09. The shares were previously bought for an average price of USD 504.88. The Time Out Group plc shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 17,850 The average price that the ETF previously sold TMO share for is USD 500.349 which is higher than the selling price of USD 419.88 on 2025-07-09. |
| AMGN - Amgen Inc | SELL | -299 @ USD 296.52 | USD -88,659 | The ETF sold 299 shares of AMGN on 2025-07-09. The shares were previously bought for an average price of USD 300.759. The Amgen Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,267 The average price that the ETF previously sold AMGN share for is USD 288.024 so the ETF has sold 299 shares on 2025-07-09 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -199 @ USD 528.13 | USD -105,098 | The ETF sold 199 shares of ISRG on 2025-07-09. The shares were previously bought for an average price of USD 535.412. The Intuitive Surgical Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,449 The average price that the ETF previously sold ISRG share for is USD 530.203 which is higher than the selling price of USD 528.13 on 2025-07-09. |
| MRK - Marks Electrical Group PLC | SELL | -1,397 @ USD 83.71 | USD -116,943 | The ETF sold 1397 shares of MRK on 2025-07-09. The shares were previously bought for an average price of USD 90.1354. The Marks Electrical Group PLC shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,976 The average price that the ETF previously sold MRK share for is USD 95.4857 which is higher than the selling price of USD 83.71 on 2025-07-09. |
| MRK - Merck & Company Inc | SELL | -1,397 @ USD 83.71 | USD -116,943 | The ETF sold 1397 shares of MRK on 2025-07-09. The shares were previously bought for an average price of USD 90.1354. The Merck & Company Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,976 The average price that the ETF previously sold MRK share for is USD 95.4857 which is higher than the selling price of USD 83.71 on 2025-07-09. |
| ABT - Abbott Laboratories | SELL | -969 @ USD 133.22 | USD -129,090 | The ETF sold 969 shares of ABT on 2025-07-09. The shares were previously bought for an average price of USD 128.101. The Abbott Laboratories shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 4,960 The average price that the ETF previously sold ABT share for is USD 120.674 so the ETF has sold 969 shares on 2025-07-09 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -503 @ USD 302.91 | USD -152,364 | The ETF sold 503 shares of UNH on 2025-07-09. The shares were previously bought for an average price of USD 495.756. The UnitedHealth Group Incorporated shares were sold for -38.9% lower than average price of previous purchases. This resulted in an overall loss of USD 97,002 The average price that the ETF previously sold UNH share for is USD 510.059 which is higher than the selling price of USD 302.91 on 2025-07-09. |
| ABBV - AbbVie Inc | SELL | -978 @ USD 190.62 | USD -186,426 | The ETF sold 978 shares of ABBV on 2025-07-09. The shares were previously bought for an average price of USD 192.168. The AbbVie Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,514 The average price that the ETF previously sold ABBV share for is USD 185.303 so the ETF has sold 978 shares on 2025-07-09 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,331 @ USD 156.28 | USD -208,009 | The ETF sold 1331 shares of JNJ on 2025-07-09. The shares were previously bought for an average price of USD 156.97. The Johnson & Johnson shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 918 The average price that the ETF previously sold JNJ share for is USD 152.699 so the ETF has sold 1331 shares on 2025-07-09 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -432 @ USD 786.92 | USD -339,949 | The ETF sold 432 shares of LLY on 2025-07-09. The shares were previously bought for an average price of USD 829.133. The Eli Lilly and Company shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 18,236 The average price that the ETF previously sold LLY share for is USD 791.855 which is higher than the selling price of USD 786.92 on 2025-07-09. |